KFA Browser > Vaksin SARS-COV-2 Recombinant Protein AD-5 NLT 4 X 10^10 VP/0,5 mL Injeksi (CONVIDECIA, 3)

Vaksin SARS-COV-2 Recombinant Protein AD-5 NLT 4 X 10^10 VP/0,5 mL Injeksi (CONVIDECIA, 3)

  1. General Information
  2. Sales Information
  3. Anatomical Therapeutic Chemical Group
  4. Identifier Reference
  5. Actual Medicinal Product (POAK)
  6. Ingredients
  7. Product Hierarchy
KFA Code (PV) 93004423
Type Vaksin
Unit of Measure (UCUM) milliliter
Smallest Logistic Unit Vial
Dosage Form Suspensi Injeksi
Drug Classification Obat Keras
Route Administration Intramuskular Injeksi (di dalam otot)

CVX Info

CVX Code 213
Vaccine Group COVID-19
CVX MVX Code 213CSB
CVX Trade Name CONVIDENCIA
NIE BPOM DKI2360300568A1
Trade Name CONVIDECIA
Manufacturer CanSino Biologics Inc.
Registrar ETANA BIOTECHNOLOGIES INDONESIA
Chemical Substance (INN) J07BX03 - Covid-19 vaccines
Anatomical Main Group J - ANTIINFECTIVES FOR SYSTEMIC USE
Therapectic Subgroup J07 - VACCINES
Pharmacological Subgroup J07B - VIRAL VACCINES
Chemical Subgroup J07BX - Other viral vaccines
Alternative Name (USAN) SARS-COV-2 (COVID-19) vaccine, vector non-replicating
NIE BPOM EUA2160300143A1 - CONVIDECIA
Kamus Farmalkes (KFA – IHS) 93004423 - Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL
NIE BPOM DKI2360300568A1 - CONVIDECIA
Name Display Name Dosage

Sars-Cov-2 (Covid-19) Vaccine, Vector Non-Replicating

Sars-Cov-2 (Covid-19) Vaccine, Vector Non-Replicating

4 10*10/0.5 mL
KFA Code (PV) Pack Type Estimated Pack Price (IDR)
- - -

Product Hierarchy